Online content falsely claiming vaccines can be distributed through the food supply has circulated for years and a new series ...
Kim V. Narry, 57 years old, head of the Institute for Basic Science (IBS) RNA Research Group and a distinguished professor at ...
The study also reviews the great potential of mRNA vaccines to treat influenza, RSV, cancer, and autoimmune diseases.
Researchers found that mRNA cancer vaccines can recruit an unexpected immune cell to launch powerful tumor-fighting responses ...
Messenger RNA (mRNA) vaccines are one of the biggest medical breakthroughs of recent years. It was first introduced during ...
Moderna (MRNA) climbed to $81.42, up 169% annually. Analysts set average target at $37 while insiders sold $6.1M worth of ...
Emcure's Gennova transfers its mRNA business to Immunoscript Life Science for ₹139 crore, focusing on core biotech operations ...
Moderna stock soars on positive updates during the Science Day presentation. Jefferies sees significant further upside in MRNA shares.
The mRNA vaccines approved to treat COVID-19 are safe and effective and show promise in treating other diseases including ...